
0:00
29:04
In this episode of The World of the API podcast, we have a chat with Teva Environmental, Social, Governance (ESG) experts, Itamar Schwartz and Adam Ajzensztejn about ESG in pharma. We talk about why ESG is such a buzz word at the moment, what impact the pharma industry can actually have, and what makes Teva's recent $5 billion sustainability-linked bond the first of its kind.
More episodes from "The World of the API"



Don't miss an episode of “The World of the API” and subscribe to it in the GetPodcast app.

